Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantation.

Henes JC, Heinzelmann F, Wacker A, Seelig HP, Klein R, Bornemann A, Faul C, Kanz L, Koetter I.

Ann Rheum Dis. 2009 Mar;68(3):447-8. doi: 10.1136/ard.2008.094755. No abstract available.

PMID:
19213752
2.

Anti-signal recognition particle-positive juvenile polymyositis successfully treated with rituximab.

Luca NJ, Atkinson A, Hawkins C, Feldman BM.

J Rheumatol. 2012 Jul;39(7):1483-5. doi: 10.3899/jrheum.111592. No abstract available.

PMID:
22753802
3.

Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.

Liewluck T.

Rheumatology (Oxford). 2009 Jan;48(1):90; author reply 90-1. doi: 10.1093/rheumatology/ken403. Epub 2008 Nov 4. No abstract available.

PMID:
18984607
4.

Autoantibody to signal recognition particle in African American girls with juvenile polymyositis.

Rouster-Stevens KA, Pachman LM.

J Rheumatol. 2008 May;35(5):927-9. Epub 2008 Mar 1.

PMID:
18322984
5.

Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up.

Bingham S, Griffiths B, McGonagle D, Snowden JA, Morgan G, Emery P.

Br J Haematol. 2001 Jun;113(3):840-1. No abstract available.

PMID:
11380480
6.

[Anti-signal recognition particle autoantibody positive myopathy].

Bodoki L, Vincze M, Hortobágyi T, Griger Z, Csonka T, Dankó K.

Ideggyogy Sz. 2014 Sep 30;67(9-10):347-53. Review. Hungarian.

PMID:
25518264
7.

[Anti-signal recognition particle (SRP) antibody positive polymyositis refractory to corticosteroid treatment].

Shirai Y, Koizumi K, Ogawa R, Suzuki T, Koido N, Ohosone Y, Akizuki S, Takada T, Hirakata M, Ishihara T.

Nihon Naika Gakkai Zasshi. 2007 Nov 10;96(11):2522-4. Japanese. No abstract available.

PMID:
18069306
8.

Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.

Suzuki S, Satoh T, Sato S, Otomo M, Hirayama Y, Sato H, Kawai M, Ishihara T, Suzuki N, Kuwana M.

Rheumatology (Oxford). 2008 Oct;47(10):1539-42. doi: 10.1093/rheumatology/ken325. Epub 2008 Aug 7.

PMID:
18687709
9.

Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.

Dimitri D, Andre C, Roucoules J, Hosseini H, Humbel RL, Authier FJ.

Muscle Nerve. 2007 Mar;35(3):389-95.

PMID:
17143889
10.

Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.

Bohgaki T, Atsumi T, Bohgaki M, Furusaki A, Kondo M, Sato-Matsumura KC, Abe R, Kataoka H, Horita T, Yasuda S, Amasaki Y, Nishio M, Sawada K, Shimizu H, Koike T.

J Rheumatol. 2009 Jun;36(6):1240-8. doi: 10.3899/jrheum.081025. Epub 2009 May 15.

PMID:
19447934
11.

Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.

Whelan BR, Isenberg DA.

Rheumatology (Oxford). 2009 May;48(5):594-5. doi: 10.1093/rheumatology/kep027. Epub 2009 Mar 1. No abstract available.

PMID:
19254917
12.

Hodgkin's lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back.

Verholen F, Terrettaz M, Roosnek E, Passweg JR, Chalandon Y.

Eur J Haematol. 2009 Sep;83(3):273-5. doi: 10.1111/j.1600-0609.2009.01282.x. Epub 2009 Jun 2. No abstract available.

PMID:
19500136
13.

Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.

Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2009 May;15(5):564-73. doi: 10.1016/j.bbmt.2009.01.011. Epub 2009 Mar 9.

14.

Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.

Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19.

15.

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.

Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socié G, Oneto R, Passweg JR; Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT-SAAWP).

Haematologica. 2009 Sep;94(9):1312-5. doi: 10.3324/haematol.2009.006916.

16.

Signal recognition antibody-positive myopathy and response to intravenous immunoglobulin G (IVIG).

Garcia-Rosell M, Moore S, Pattanaik D, Menon Y, Bertorini T, Carbone L.

J Clin Rheumatol. 2013 Jun;19(4):214-7. doi: 10.1097/RHU.0b013e31828e6442. No abstract available.

PMID:
23669796
17.

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.

Gupta V, Kröger N, Aschan J, Xu W, Leber B, Dalley C, Sabloff M, Lipton JH, Messner H, Brune M.

Bone Marrow Transplant. 2009 Sep;44(5):317-20. doi: 10.1038/bmt.2009.10. Epub 2009 Feb 23. No abstract available.

PMID:
19234505
18.

Defining conditioning regimens for BMT--recognition of "regimens of intermediate intensity".

Russell NH, Byrne JI, Robinson SP.

Biol Blood Marrow Transplant. 2009 Jul;15(7):890-1; author reply 891. doi: 10.1016/j.bbmt.2009.02.012. Epub 2009 May 14. No abstract available.

19.

Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.

Ringdén O, Labopin M, Ehninger G, Niederwieser D, Olsson R, Basara N, Finke J, Schwerdtfeger R, Eder M, Bunjes D, Gorin NC, Mohty M, Rocha V.

J Clin Oncol. 2009 Sep 20;27(27):4570-7. doi: 10.1200/JCO.2008.20.9692. Epub 2009 Aug 3.

PMID:
19652066
20.

Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Costa LJ, Kumar S, Dispenzieri A, Hayman SE, Buadi FK, Dingli D, Litzow MR, Gertz MA, Lacy MQ.

Leuk Lymphoma. 2009 May;50(5):781-7. doi: 10.1080/10428190902803644.

PMID:
19330657

Supplemental Content

Support Center